Quest Diagnostics EPS Beats Expectations
Quest Diagnostics reported strong third-quarter earnings driven by acquisitions, with revenue surpassing expectations, though profit margins faced pressure.
Lockheed Martin reports EPS beat, revenue miss
CNBC’s Morgan Brennan joins 'Squawk Box' to report on the company's quarterly earnings results. 31 Make-Ahead Casseroles We’re Eating All Fall Long
Over 60% of companies that reported earnings this week beat EPS and revenue estimates - Earnings Scorecard
Wall Street’s bull run continued this week, with both the Dow and the S&P 500 touching fresh record highs. The Dow closed at a record high, on Thursday, while t
Texas Instruments (TXN) Q3 2024 earnings results beat revenue and EPS expectations
Texas Instruments published its Q3 2024 earnings report after markets closed today. The company reported $4.15 billion in revenue, edging out the expectation of $4.1 billion. As for EPS, Texas Instruments earned $1.47 per-share against the expected $1.38.
Quest Diagnostics reports Q3 adjusted EPS $2.30, consensus $2.26
Reports Q3 revenue $2.49B, consensus $2.42B. “We delivered a strong third quarter, with total revenue growth of 8.5%, including 4.2%
Quest Diagnostics beats quarterly results estimates on diagnostic test demand
Laboratory operator Quest Diagnostics beat Wall Street estimates for third-quarter profit and revenue on Tuesday, helped by robust demand for its diagnostic tests. Demand for diagnostic checkups has grown in recent quarters as more people,
Quest Boosts EPS, Revenue Views After Strong 3Q Earnings
Quest Diagnostics boosted projections for 2024 earnings and revenue after logging brisk third-quarter growth, buoyed by increased discretionary health-care activity in the U.S. and the recent acquisition of a Canadian rival.
Quest Diagnostics Q3 Profit Increases, Beats Estimates
Quest Diagnostics (DGX) released a profit for its third quarter that increased from last year and beat the Street estimates. The
Quest Diagnostics (DGX) Beats Q3 Earnings and Revenue Estimates
Quest Diagnostics (DGX) came out with quarterly earnings of $2.30 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.22 per share a year ago. These figures are adjusted for non-recurring items.
Manhattan Associates: Q3 EPS Jumps 30%
Manhattan Associates reports record Q3 2024 revenue and earnings driven by cloud-native transition. Manhattan Associates ( ...
Lockheed Martin Raises Annual EPS Guidance But Struggles With Sales; Stock Slips
LMT's Q3 results were mixed, with net sales missing consensus but adjusted EPS beating it. The company also raised its FY24 ...
Starbucks Q4 Preliminary EPS Down; Suspends FY25 Guidance
Starbucks Corp. (SBUX) reported that its preliminary earnings per share for the fourth quarter of fiscal year 2024 was $0.80, down ...
EPS: Reasonable Valuations, Mixed Performance
EPS offers value-oriented exposure to U.S. large-cap companies but has historically underperformed compared to broader market ...
GE Aerospace's Q3 Results Solid, But Segments Tell Different Stories: Analyst
Goldman Sachs analyst Noah Poponak expresses their view on GE Aerospace‘s (NYSE:GE) third-quarter 2024 results. The company ...
Enid News & Eagle1d
EPS board to meet Tuesday
Enid Public Schools Board of Education will be Tuesday night, Oct. 22, 2024, because of fall break. The meeting will be at 6 ...
Tutor Perini sees negative Q3 EPS, withdraws 2024 EPS guidance
Tutor Perini (TPC) provided an update regarding several recent developments, including the settlement of various project-related disputes, ...
Tesla Q3 Earnings: Troy Teslike, Gary Black Expects EPS To Fall Below Estimates But Dan Ives Is Optimistic About Elon Musk Addressing EV Demand, Autonomous Driving
EV giant Tesla Inc. (NASDAQ:TSLA) is slated to post its financial results for the third quarter after the market closes on ...